Application Deadline U.S. citizens: 2025-26 Fulbright U.S. Scholar Competition Deadline is Monday, September 16, 2024 at 5 PM EST. Find out more.
Home Country Tunisia Preclinical Study of a Novel Immunoproteasome Inhibitor in Inflammatory Breast Cancer Models Program Fulbright Visiting Scholar Program Program Country Tunisia Grant Activity Type Research Discipline Biology Specialization Oncology and Cancer Biology Academic Year 2019-2020 Dates October 2019 - October 2020 Flex No Scholar type Non-U.S. (Visiting) Scholar Project Title Preclinical Study of a Novel Immunoproteasome Inhibitor in Inflammatory Breast Cancer Models Scholar Information Grantee Marwa Manai Title Postdoctoral Student Institution Faculty of Sciences of Tunis (FST) /and/ Salah Azaiez Institute (ISA) Host Institutions Institution University of Texas MD Anderson Cancer Center Faculty Naoto Ueno Host Department Department of Breast Medical Oncology
Preclinical Study of a Novel Immunoproteasome Inhibitor in Inflammatory Breast Cancer Models Program Fulbright Visiting Scholar Program Program Country Tunisia Grant Activity Type Research Discipline Biology Specialization Oncology and Cancer Biology Academic Year 2019-2020 Dates October 2019 - October 2020 Flex No Scholar type Non-U.S. (Visiting) Scholar Project Title Preclinical Study of a Novel Immunoproteasome Inhibitor in Inflammatory Breast Cancer Models Scholar Information Grantee Marwa Manai Title Postdoctoral Student Institution Faculty of Sciences of Tunis (FST) /and/ Salah Azaiez Institute (ISA) Host Institutions Institution University of Texas MD Anderson Cancer Center Faculty Naoto Ueno Host Department Department of Breast Medical Oncology